SHERIDAN, Wyo., Oct. 15, 2026 /PRNewswire/ -- The global cancer diagnostics market is valued at USD 29.3 billion in 2026 and is projected to reach USD 41.5 billion by 2031, growing at a CAGR of 7.2% over the forecast period (2026–2031), according to a new study by Wissen Research.

The starting point is simple: more people need testing. The International Agency for Research on Cancer (IARC) counted about 20 million new cancer cases and 9.7 million cancer deaths worldwide in 2022, and expects annual new cases to pass 35 million by 2050. Every one of those patients may need screening, diagnosis, staging, molecular characterization, and follow-up, so the load on diagnostic tools keeps building.

What is changing faster is how the testing gets done. Diagnosis that once leaned mostly on imaging and a pathologist's reading of tissue is becoming a layered process that also draws on digital pathology, molecular and genomic tests, liquid biopsy, and AI.

Get a Free Sample of This Report to Explore Key Findings and Data: https://www.wissenresearch.com/request-a-sample/?report=cancer-diagnostics-market

Diagnosis Is Becoming a Stack: Imaging and Pathology Now Share the Work With Molecular and AI Tools

Mammography, CT, MRI, and tissue pathology are still the backbone of cancer diagnosis. Pathology in particular remains central, since examining tissue and cells under the microscope is how a cancer is confirmed, and immunohistochemistry adds protein-level detail that helps pin down the tumor type and the right therapy. What the report highlights is the layer being added on top. According to the National Cancer Institute, an advanced diagnosis now tells clinicians not only where the cancer is and how far it has spread, but also what type it is and which genetic and molecular changes could influence treatment.

That is where precision oncology comes in. Molecular testing is used to profile tumors and find markers that guide treatment, and next-generation sequencing based comprehensive genomic profiling lets labs look at several biomarkers from a single sample. The FDA's list of companion diagnostics, which identify patients likely to benefit from a particular therapy, those at risk of severe side effects, or how well a treatment is working, is increasingly populated with NGS and liquid biopsy tests. AI is joining the mix as well. Tools are being built for medical imaging, digital pathology, and lesion detection and classification, the FDA has approved AI systems for medical use, and the NCI continues to advance research on AI in cancer imaging.

Liquid Biopsy Is Moving Up, But Tissue Isn't Going Anywhere

Liquid biopsy is fast becoming an important tool because it can pick up signs of cancer in blood or other body fluids instead of requiring a tissue sample each time. The NCI describes it as testing blood for cancer cells or pieces of tumor DNA, with uses that include diagnosis, treatment decisions, tracking response, and spotting recurrence. The FDA has already approved liquid biopsy companion diagnostics, including tests that use NGS to analyze circulating DNA from plasma.

The report is careful about the limits, though. Liquid biopsy is not yet ready to replace tissue-based diagnostics across the board, and questions about sensitivity, specificity, clinical utility, and validation remain open. The same caution applies to multi-cancer detection tests, where the NCI is still studying how they should fit into screening and what they would mean for patient outcomes.

What's Fueling Growth in the Cancer Diagnostics Market

- More patients to test: Demographic change is expanding the number of people who need screening, diagnosis, staging, and monitoring.

- A push for earlier detection: The WHO separates early diagnosis in people with symptoms from screening in people without them, and says earlier detection leads to better treatment outcomes. Screening for breast, cervical, colorectal, and lung cancer keeps imaging, cytology, and other tests in steady demand.

- Precision oncology: Molecular testing is now used to profile tumors and find markers that decide treatment, lifting demand for molecular and biomarker diagnostics.

- Genomic testing and liquid biopsy: NGS-based profiling checks multiple genetic changes at once, while liquid biopsy looks at tumor-derived DNA in blood or other fluids.

- AI and digitalization: AI is being developed for medical imaging, digital pathology, lesion detection and classification, and handling complex diagnostic data.

- Asia Pacific build-out: New hospitals, diagnostic labs, and cancer hospitals, along with public screening programs, are widening access to modern diagnostics across the region.

Challenges Facing the Cancer Diagnostics Market

A new cancer test has to clear a high bar before it earns clinical trust. Developers contend with diagnostic accuracy, sample quality, tumor heterogeneity, biomarker variability, false positives and false negatives, turnaround time, reimbursement, data interoperability, and regulatory requirements. Each technology has its own version of the problem. Molecular testing can be limited by scarce tissue and by tumors that contain genetically distinct populations. Liquid biopsy has to detect very low concentrations of tumor material. AI tools for imaging and pathology need the right datasets and proper clinical validation.

There is also a harder question behind the technical ones. A test can reveal a biomarker or an abnormality without proving that using it improves patient outcomes, which is why clinical utility matters so much for newer approaches such as multi-cancer detection.

Recent Strategic Developments in the Cancer Diagnostics Market

On September 28, 2026, Leica Biosystems, a subsidiary of Danaher Corporation, completed its acquisition of StatLab Medical Products. The deal widens Leica's anatomic pathology portfolio across specimen collection, preparation, staining, digital imaging, and AI-enabled diagnosis, strengthening its end-to-end pathology capabilities and supporting faster, more standardized cancer diagnostic workflows.

On July 27, 2026, Siemens Healthineers AG and Vanderbilt Health entered an $87 million multi-year partnership to modernize diagnostic imaging and radiation oncology. The agreement covers MRI, CT, molecular imaging, and interventional radiology systems, and advances AI-enabled radiology, personalized medicine, and workflow automation.

On May 7, 2026, F. Hoffmann-La Roche Ltd entered a definitive agreement to acquire PathAI for up to $1.05 billion, including $750 million upfront and milestone payments. The acquisition was expected to strengthen Roche's digital pathology and AI capabilities by integrating PathAI's AI-powered pathology platform with Roche's oncology diagnostics and companion diagnostics portfolio.

Taken together, the three deals put money behind pathology, imaging, and AI-enabled workflows.

Key Insights from Cancer Diagnostics Market Analysis

- IVD testing held the largest share by product type in 2025, reflecting how widely laboratory testing is used for diagnosis, disease characterization, biomarker assessment, and treatment decisions. The category covers kits and reagents, PCR and NGS instruments, in situ hybridization, immunohistochemistry, and other laboratory technologies.

- Diagnosis and disease characterization held the largest share by application in 2025, because malignancy has to be confirmed and its biology characterized before treatment begins. Molecular and genomic testing identifies mutations, gene fusions, biomarker expression, microsatellite instability, and mismatch-repair status that can steer treatment choice.

- North America held the largest regional share in 2025, supported by advanced medical infrastructure, established cancer-screening programs, advanced imaging and laboratory technology, molecular diagnostics, and a number of global diagnostic and medical-device leaders.

- Asia Pacific is the fastest-growing region, driven by a rising cancer burden, better healthcare infrastructure, and investment in diagnostic facilities.

- The market is moderately consolidated in established diagnostic technologies but remains fragmented across emerging molecular, liquid biopsy, digital pathology, and AI-enabled applications, where major diagnostic and life-sciences companies compete alongside specialized molecular-diagnostic and oncology-focused technology companies.

Key Players in the Cancer Diagnostics Market

Leading companies in the cancer diagnostics market are focusing on medical imaging, pathology, molecular diagnostics, genomic testing, companion diagnostics, liquid biopsy, cancer screening, digital pathology, artificial intelligence, and expansion of precision-oncology testing.

The report names F. Hoffmann-La Roche, Danaher, Abbott Laboratories, Thermo Fisher Scientific, and Siemens Healthineers as the top five players, with established positions across pathology, molecular diagnostics, genomic testing, medical imaging, biomarker testing, laboratory diagnostics, and precision oncology. Recent moves show where several of them are heading:

- Roche (Switzerland): digital pathology, AI, and companion diagnostics, reinforced by its agreement to acquire PathAI.

- Danaher (US): anatomic pathology through Leica Biosystems and its StatLab acquisition.

- Siemens Healthineers (Germany): diagnostic imaging and radiation oncology, including its partnership with Vanderbilt Health.

- Abbott (US) and Thermo Fisher Scientific (US): also in the top five, and, along with GE HealthCare and Hologic, among the companies the report points to as active in North America.

Other companies covered in the report include QIAGEN, Illumina, Agilent Technologies, Becton Dickinson, Exact Sciences, Guardant Health, Natera, GRAIL, and Tempus AI.

Regional Analysis and Growth Opportunities

North America leads the cancer diagnostics market. The U.S.

The article explains how clear, year-round benefits communication helps employees understand and use the workplace resources available to them.

MONTGOMERY, Ala., Oct. 15, 2026 /PRNewswire/ -- What workplace benefits are employees missing without even realizing it? HelloNation answers that question in an article featuring insights from Benefits Consulting Expert Stacia Robinson of BeneChoice Companies LLC in Montgomery, Alabama.

The article examines why many employees fail to take full advantage of valuable workplace benefits, even as employers invest significant resources in comprehensive programs. Health insurance, retirement plans, wellness initiatives, mental health support, flexible spending accounts, and professional development opportunities can improve employees' financial well-being and quality of life. According to the HelloNation article, many workers overlook these offerings because the information is unfamiliar, difficult to understand, or seems unrelated to their immediate priorities.

The article explains that timing is one of the most common barriers. Employees often receive detailed information about employee benefits only during onboarding or annual enrollment periods. During these busy moments, workers are expected to absorb a large amount of information while focusing on new responsibilities or meeting enrollment deadlines. As a result, employees easily forget important details before they become relevant.

The HelloNation article also notes that complex terminology and lengthy documentation make benefits communication more difficult than necessary. Employees may hesitate to ask questions because they assume they should already understand the material. Others postpone learning about available programs until they need them, only to discover they have missed an enrollment period or failed to take advantage of a benefit that could have provided meaningful assistance much sooner.

Benefits Consulting Expert Stacia Robinson's featured insights emphasize that organizations can improve employee benefits participation by making information available year-round rather than limiting communication to enrollment periods. The article recommends presenting one benefit at a time using plain language and practical examples that connect directly to everyday situations employees face.

The article illustrates this approach by showing how a health savings account can help reduce medical expenses and how an employee assistance program offers confidential support when personal or workplace challenges arise. Presenting benefits through familiar situations makes them easier for employees to understand, remember, and use when appropriate.

Regular reminders also strengthen awareness of workplace benefits, according to the article. Seasonal updates, brief educational messages, and examples tied to everyday decisions help reinforce key information without overwhelming employees. Managers and human resources professionals help by directing employees to reliable resources and encouraging questions when they need clarification.

The article further explains that growing businesses often face additional communication challenges as new benefit offerings are introduced and eligibility requirements evolve. Existing employees may not realize that available coverage has expanded or changed. Keeping benefits communication current helps employees stay informed and build confidence in their options.

The HelloNation article also encourages employers to gather employee feedback to better understand which programs cause confusion. Surveys, informal conversations, and frequently asked questions can identify misunderstandings and help organizations improve future communication. Real-life examples also make a meaningful difference by helping employees recognize how a retirement savings plan can grow over time or how wellness programs and preventive care benefits fit naturally into everyday life.

According to the article, better communication creates value for both employees and employers. Employees who understand their options are more likely to participate in available programs, make informed decisions, and appreciate the resources available to them. Employers, in turn, receive greater value from their investment while fostering a workplace culture built on transparency, understanding, and informed decision-making.

Why Employees Overlook Valuable Workplace Benefits features insights from Stacia Robinson, Benefits Consulting Expert in Montgomery, Alabama, in HelloNation.

About HelloNation

HelloNation is America's Good News Network, a premier media platform built on the idea that good news travels faster when real people tell real stories. Through its community-focused publications and innovative "edvertising" approach, HelloNation delivers content that informs, inspires, and spotlights the leaders making a meaningful impact in their communities.

SOURCE HelloNation

Share this article

Physician-founded health company builds on its roots in recovery nutrition and education as it expands support for patients navigating medical weight management

BOSTON, Oct. 15, 2026 /PRNewswire/ -- HealFast, a physician-founded health and wellness company focused on supporting people through demanding health transitions, today announced the next phase of its growth: an expansion into telehealth focused on metabolic health and support for individuals navigating GLP-1-assisted weight-management journeys.

The expansion builds on HealFast's original mission to address the nutritional and educational needs arising from significant periods of change; including surgery, injury and childbirth. Now as more patients begin medical weight-management journeys, HealFast plans to bring that same patient-first approach to this rapidly evolving area of health care.

"From the beginning, HealFast was built around meaningful moments of transition – such as a change in their health - and want more than a simple transaction," said Justin Samra, co-founder and CEO of HealFast. "Our role has always been to unlock patients' optimal outcomes by asking and delivering what they require in that moment – whether better information, nutritional support or simply a clearer path forward. We see trusted telehealth access and metabolic support as a natural extension of our mission."

Supporting the journey beyond the prescription

GLP-1 medications have reshaped the medical weight-management landscape and introduced new opportunities for patients working with licensed health care professionals. They have also created a growing need for practical education and support around the broader patient experience.

HealFast's expansion into metabolic health is being developed around a simple principle: medication may be one part of a patient's journey, but it is not the entire journey.

The company is building a broader support ecosystem intended to connect appropriate access to medical care with nutrition, education and patient-focused resources. Additional details regarding HealFast's telehealth capabilities and metabolic-health offerings will be announced separately.

"As physicians, we know that a prescription exists within a much larger health journey," said Dr.Myroslav Figura, co-founder of HealFast. "Patients have questions about nutrition, lifestyle, expectations and how to take care of themselves throughout periods of significant change. Our goal is to help patients feel better informed and better supported while keeping individual medical decisions where they belong - between the patient and their licensed health care provider."

From recovery support to metabolic health

HealFast originally developed products and educational resources for people preparing for and recovering from surgery and other physically demanding health events. That experience shaped the company's broader view that major health transitions often extend beyond an individual procedure, product or prescription.

The company's move into telehealth, weight loss, and metabolic health reflects an expansion of that philosophy to unlock optimal patient outcomes.

HealFast expects to introduce additional resources, services and products supporting patients on medical weight-management journeys over the coming months.

To learn more about HealFast and its approach to patient support, visit https://healfastrx.com/.

About HealFast

HealFast is a physician-founded health and wellness company focused on helping people navigate some of life's most demanding health transitions. The company began by developing nutritional support and educational resources for patients surrounding surgery, injury and childbirth and is expanding its patient-first model into metabolic health and GLP-1-supported weight-management journeys. HealFast develops products, education and services intended to help patients feel informed, prepared and supported throughout their health journey.

SOURCE HealFast, Inc.

Share this article

RANCHO CUCAMONGA, Calif., Oct. 15, 2026 /PRNewswire/ -- Inland Empire Health Plan (IEHP) has been named as a Fortune magazine and Great Place To Work® 2026 Best Workplaces in Health Care™, ranking No. 34 on the nationally recognized list.

This is the fifth year in a row the local health plan has been recognized by the publication and Great Place To Work. The local health plan was credited for fostering a positive, uplifting environment with opportunities for personal and career development.

"What an incredible recognition to receive as we celebrate 30 years of 'Caring Together,'" said IEHP Chief Executive Officer Jarrod McNaughton. "This honor reflects the culture our team has built — one rooted in inclusion, opportunity and a shared commitment to our mission."

The Best Workplaces Health Care award is based on analysis of survey responses from nearly 222,000 employees at Great Place To Work™ companies in the healthcare industry. IEHP earned designation in April as a Great Place To Work for the sixth year in a row.

The survey tracks responses in five categories and 15 subcategories such as credibility and respect and how fair employees are treated throughout the organizations.

The 2026 Great Place To Work survey was sent to more than 3,800 IEHP team members, with 87% surveyed saying the local health plan is a great place to work.

"Our team members are deeply committed to serving our members and communities, and we are equally committed to investing in their growth, development and long-term success," said IEHP Chief People Officer Supriya Sood. "Our hope is that every team member who walks through our doors feels valued and appreciated throughout their career journey with us."

IEHP and others featured in 2026 were selected based on their ability to offer positive outcomes for employees regardless of job role, work status or other demographic factors, the company said.

"Congratulations to the Fortune Best Workplaces in Health Care," said CEO of Great Place to Work Michael C. Bush. "People are at the heart of work in every industry, and healthcare is no exception. These companies show how delivering for your people drives financial performance and turns the future into the confidence to win."

To learn more about the local health plan, go to www.iehp.org.

A list of current job postings and benefits is available at careers.iehp.org.

About IEHP

With a mission to heal and inspire the human spirit, Inland Empire Health Plan (IEHP) is a local public health plan that serves 1.4 million residents of San Bernardino and Riverside counties. Founded in 1996 as a government entity, IEHP is one of the top 5 largest Medicaid health plans and the largest publicly operated Dual Eligible Special Needs Plan (for those with both Medicare and Medicaid) in the nation. IEHP is also the lowest-cost Silver plan in the region for Covered California. For the sixth consecutive year, the health plan is proudly certified as A Great Place To Work®.

Today, IEHP maintains a robust network of more than 10,000 quality providers and is supported by nearly 3,600 dedicated team members who remain committed to the vision: We will not rest until our communities enjoy optimal care and vibrant health. To learn more, go to iehp.org.

About the Fortune Best Workplaces in Health Care List

Great Place To Work selected the 2026 Fortune Best Workplaces in Health Care by analyzing confidential survey responses from more than 1.3 million employees, representing the experiences of more than 7.3 million employees in 2025 and 2026. Of those responses, nearly 222,000 were from employees at Great Place To Work Certified companies in the health care industry, and this ranking is based on that feedback. Companies with 10 to 999 employees competed in the small and medium category. Companies with 1,000 or more employees were considered for the large category. Read the full methodology.

To get on this list next year, start here.

About Great Place To Work

As the global authority on workplace culture, Great Place To Work, a UKG company, brings 30 years of groundbreaking research and data to help every place become a great place to work for all. Its proprietary platform and Great Place To Work Model help companies evaluate the experience of every employee, with exemplary workplaces becoming Great Place To Work Certified and receiving recognition on a coveted Best Workplaces list.

Follow Great Place To Work on LinkedIn, X, and Instagram, and sign up for the Great Place To Work LinkedIn newsletter, Culture Edge, to get the latest research on what drives business success.

About Fortune Media

Fortune is a global multi-platform media company built on a legacy of trusted, award-winning reporting and information for those who want to make business better. Independently owned, Fortune tells the stories of the world's biggest companies and their leaders as well as a new generation of innovators who are moving business forward. Digitally and in print, Fortune measures corporate performance through rigorous benchmarks, and holds companies accountable, in regions around the world. Its iconic rankings include Fortune 500, Fortune Global 500, Most Powerful Women, and World's Most Admired Companies. Fortune builds world-class communities by convening industry thought leaders for exclusive summits and conferences, including the Fortune Global Forum, Fortune Brainstorm Tech, and Fortune Most Powerful Women. For more information, visit fortune.com.

SOURCE Inland Empire Health Plan (IEHP)

Share this article

BSR REIT Announces October 2026 Cash Distribution

LITTLE ROCK, Ark. and TORONTO, Oct. 15, 2026 /PRNewswire/ -- BSR Real Estate Investment Trust (the "REIT") (NYSE: BSRT) (TSX: BSRT.UN) today announced a cash distribution of US$0.0467 per REIT unit for the month of October 2026, representing US$0.56 per REIT unit on an annualized basis. Payment will be made on November 16, 2026 to unitholders of record as at October 30, 2026.

About BSR Real Estate Investment Trust

BSR Real Estate Investment Trust is an internally managed, unincorporated, open-ended real estate investment trust established pursuant to a declaration of trust under the laws of the Province of Ontario. The REIT owns a portfolio of multifamily garden-style residential properties located in attractive primary markets in the Sunbelt region of the United States.

Forward-Looking Statements

This news release may contain forward-looking statements (within the meaning of applicable securities laws) relating to the business of the REIT. Forward-looking statements are identified by words such as "believe", "anticipate", "project", "expect", "intend", "plan", "will", "may", "estimate" and other similar expressions. These statements are based on the REIT's expectations, estimates, forecasts and projections and include, without limitation, statements regarding the intended monthly distributions of the REIT. The forward-looking statements in this news release are based on certain assumptions including, without limitation, that the REIT will have sufficient cash to pay its distributions. They are not guarantees of future performance and involve risks and uncertainties that are difficult to control or predict. A number of factors could cause actual results to differ materially from the results discussed in the forward-looking statements, including, but not limited to, the factors discussed under the heading "Risk Factors" in the REIT's Q2 2026 Management's Discussion & Analysis dated August 12, 2026 which is available at www.sedarplus.ca. There can be no assurance that forward-looking statements will prove to be accurate as actual outcomes and results may differ materially from those expressed in these forward-looking statements. Readers, therefore, should not place undue reliance on any such forward-looking statements. Further, these forward-looking statements are made as of the date of this news release and, except as expressly required by applicable law, the REIT assumes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.

SOURCE BSR Real Estate Investment Trust

Share this article

The relaunched brand builds every sofa to order in its own factory. Its best-selling Kova comes in two looks and the customer's choice of comfort, with a free cushion exchange in the home if the comfort isn't right.

CYPRESS, Calif., Oct. 15, 2026 /PRNewswire/ -- Albany Park relaunched today as a sofa brand that makes what it sells. Most sofa brands do not make the sofas they sell; imported or built to order, most sofas come from someone else's factory. Albany Park, owned by furniture manufacturer Exemplis since 2022, builds every sofa to order in its own factory in El Florido, Baja California, Mexico, and ships it in seven days, with the delivery window shown by ZIP code before the customer orders.

A sofa is one of the most considered purchases in the home: how it looks, how it feels, what's inside it, when it's coming, what it costs, and who stands behind it. Albany Park built the relaunch around answering each of those plainly, before the order is placed.

"People have been asked to make the same tradeoff in furniture for years," said Paul DeVries, CEO of Albany Park. "Buy something off the shelf, or wait to have something made for you. We rebuilt Albany Park around the idea that you shouldn't have to settle. We make beautiful, comfortable sofas, built to order, quickly and affordably. The sofa you want. Made for you in seven days."

Being the maker is the reason behind the brand's promises. It's how Albany Park's parent company, Exemplis, has worked for thirty years: building furniture for offices, universities, and hospitals in its own factories, with more than 2,000 craftspeople. Albany Park builds sofas the same way. Its own people build the frame, make the cushions, upholster the sofa, and inspect it before it leaves. We build it. We know it. We stand behind it.

Kova, the brand's best-selling modular sofa, comes in two looks: Kova Box, the tailored one, and Kova Pillow, the relaxed one. Every Kova is built in the customer's choice of comfort, soft, medium, or firm. If the comfort turns out not to be right, a white-glove technician exchanges the cushions in the customer's home, at no cost: one free exchange within 60 days of delivery. The comfort choice and the exchange are available on Kova now and coming to the brand's Barton and Lido collections.

The brand has also published its pricing rules: no inflated reference prices, no perpetual markdowns, and a 25% ceiling on a few real sales events a year, with end dates that never move. The price you see is the price Albany Park intends to sell at.

Albany Park sofas are available at AlbanyPark.com. Make yourself comfortable.

About Albany Park:

Albany Park makes its own sofas, built to order in its own factory in El Florido, Baja California, Mexico, in seven days, with thirty years of furniture-making behind it through its parent company, Exemplis, and the Maker's Warranty behind every sofa. From our hands to your home.

Media Contact

The Zimmerman Agency

Madeleine Moench

[email protected]

SOURCE Albany Park

Share this article

ELKHART, Ind., Oct. 15, 2026 /PRNewswire/ -- Patrick Industries, Inc. (NASDAQ: PATK) ("Patrick" or the "Company") today announced that it will release its third quarter and nine months 2026 financial results before the market opens on Thursday, October 29, 2026.

Patrick Industries will host a conference call on Thursday, October 29, 2026, at 10:00 a.m. Eastern Time to discuss results and other business matters. Participation in the question-and-answer session of the call will be limited to institutional investors and analysts. The dial-in number for the live conference call is (877) 407-9036. Interested parties are invited to listen to a live webcast of the call on Patrick's website at www.patrickind.com under "Investors." A replay of the conference call will also be available via the Company's investor relations website.

About Patrick Industries, Inc.

Patrick (NASDAQ: PATK) is a leading component solutions provider serving original equipment manufacturers and aftermarket customers in the RV, Marine, Powersports and Housing markets. Since 1959, Patrick has empowered manufacturers and outdoor enthusiasts to achieve next-level recreation experiences. Our customer-focused approach brings together design, manufacturing, distribution, and transportation in a full solutions model that defines us as a trusted partner. Patrick is home to more than 85 leading brands, all united by a commitment to quality, customer service, and innovation. Headquartered in Elkhart, IN, Patrick employs approximately 10,000 skilled team members throughout the United States. For more information on Patrick, our brands, and products, please visit www.patrickind.com.

Forward-Looking Statements

This press release contains certain statements related to future results, our intentions, beliefs and expectations or predictions for the future, which are forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Any projections of financial performance or statements concerning expectations as to future developments should not be construed in any manner as a guarantee that such results or developments will, in fact, occur. There can be no assurance that any forward-looking statement will be realized or that actual results will not be significantly different from that set forth in such forward-looking statement. Information about certain risks that could affect our business and cause actual results to differ from those expressed or implied in the forward-looking statements is contained in the section entitled "Risk Factors" in the Company's Annual Report on Form 10-K for the year ended December 31, 2025, and in the Company's Forms 10-Q for subsequent quarterly periods, which are filed with the Securities and Exchange Commission ("SEC") and are available on the SEC's website at www.sec.gov. Each forward-looking statement speaks only as of the date of this press release, and we undertake no obligation to update any forward-looking statement to reflect events or circumstances occurring after the date on which it is made.

Contact:

Steve O'Hara

Vice President of Investor Relations

[email protected]

574.294.7511

SOURCE Patrick Industries, Inc.

Share this article

CONSHOHOCKEN, Pa., Oct. 15, 2026 /PRNewswire/ -- Quaker Houghton (NYSE: KWR) today announced the following schedule and contact information for its third quarter 2026 earnings release and investor call.

About Quaker Houghton

Quaker Houghton is the global leader in industrial process fluids. With a presence around the world, including operations in over 25 countries, our customers include thousands of the world's most advanced and specialized steel, aluminum, automotive, aerospace, offshore, container, mining, and metalworking companies. Our high-performing, innovative and sustainable solutions are backed by best-in-class technology, deep process knowledge and customized services. With approximately 4,700 employees, including chemists, engineers and industry experts, we partner with our customers to improve their operations so they can run even more efficiently, even more effectively, whatever comes next. Quaker Houghton is headquartered in Conshohocken, Pennsylvania, located near Philadelphia in the United States. Visit quakerhoughton.com to learn more.

SOURCE Quaker Houghton

Share this article

CLEVELAND, Oct. 15, 2026 /PRNewswire/ -- Hyster-Yale, Inc. (NYSE: HY) today announced the appointment of Matthew J. Cornell as Senior Vice President and Chief Financial Officer, effective November 1, 2026.

Mr. Cornell most recently served as President and General Manager of Stanley Black & Decker's Specialty Tools & Storage Solutions, a global operating unit. Prior to that, he served as Chief Financial Officer of Stanley Black & Decker's Industrial Segment.

Mr. Cornell's selection is the result of an extensive search process designed to identify a leader with significant financial and operating experience in global industrial businesses. Over a career spanning more than two decades, he has led finance organizations and operating businesses across North America and Europe, with experience in financial planning and analysis, business performance management, manufacturing operations, capital allocation, and leadership of publicly reported business segments. He also brings direct operating leadership experience, having led global businesses with full profit and loss responsibility.

In his role as Senior Vice President and Chief Financial Officer, Mr. Cornell will oversee the Company's financial strategy and execution as well as Hyster-Yale's finance, accounting, investor relations, tax and treasury functions. His combination of financial leadership, public company experience, and operating expertise is expected to support the Company's continued focus on operational execution, disciplined capital allocation, and long-term value creation.

Mr. Cornell earned a Bachelor of Science in Economics, cum laude, from the University of Pennsylvania, Wharton School of Business, with concentrations in Finance and Marketing.

About Hyster-Yale, Inc.

Hyster-Yale, Inc., headquartered in Cleveland, Ohio, is a globally integrated company offering a full line of lift trucks and solutions, including attachments aimed at meeting the specific materials handling needs of its customers. Hyster-Yale's vision is to transform the way the world moves materials from Port to Home and deliver on its customer promises of: (1) thoroughly understanding customer applications and offering optimal solutions that will improve productivity at the lowest cost of ownership, and (2) providing exceptional customer care to create increasing value from initial engagement through the product lifecycle.

The Company's wholly owned operating subsidiary, Hyster-Yale Materials Handling, Inc., designs, engineers, manufactures, sells and services a comprehensive line of lift trucks, aftermarket parts and technology and energy solutions marketed globally under the Hyster®, Yale®, Maximal®, and Nuvera® brand names. Hyster-Yale Materials Handling's subsidiary, Bolzoni S.p.A., is a leading worldwide producer of attachments, forks and lift tables marketed under the Bolzoni®, Auramo® and Meyer® brand names. Hyster-Yale Materials Handling also has an unconsolidated joint venture in Japan with Sumitomo NACCO Forklift Co. Ltd. Hyster-Yale Materials Handling, Inc., is a wholly owned subsidiary of Hyster-Yale, Inc. (NYSE: HY). For more information about Hyster-Yale and its subsidiaries, visit the Company's website at www.hyster-yale.com.

Forward-looking Statements Disclaimer

The statements contained in this news release that are not historical facts are "forward-looking statements." These forward-looking statements are made subject to certain risks and uncertainties, which could cause actual results to differ materially from those presented. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. The Company undertakes no obligation to publicly revise these forward-looking statements to reflect events or circumstances that arise after the date hereof. Among the factors that could cause plans, actions and results to differ materially from current expectations are, without limitation: (1) delays in delivery and other supply chain disruptions, or increases in costs as a result of inflation or otherwise, including materials, critical components and transportation costs and shortages, the effects of tariffs on raw materials or sourced products, and labor, or changes in or unavailability of quality suppliers or transporters, including the impacts of the foregoing risks on the Company's liquidity, (2) impacts resulting from sustained or increased trade barriers and restrictions on international trade, including as a result of previously announced, and potentially new, changes to U.S. trade policy and tariffs as well as retaliatory or other tariffs imposed by other countries where the Company does business, (3) the Company's ability to recover previously paid tariffs imposed under the International Emergency Economic Powers Act, (4) delays in manufacturing and delivery schedules, (5) reduction in demand for lift trucks, attachments and related parts and service on a global basis, including any cyclical reduction in demand in the lift truck industry, (6) customer acceptance of pricing, (7) customer acceptance of, changes in the costs of, or delays in the development of new products, (8) the ability of Hyster-Yale and its dealers, suppliers and end-users to access credit, or obtain financing at reasonable rates, or at all, as a result of interest rate volatility and current economic and market conditions, including inflation, (9) unfavorable effects of geopolitical and legislative developments on global operations, including without limitation the entry into new trade agreements and the imposition of tariffs and/or economic sanctions, including the Uyghur Forced Labor Prevention Act which could impact Hyster-Yale's imports from China, as well as armed conflicts, including the Iran conflict, the Russia/Ukraine conflict, the Israel and Gaza conflict and/or the conflict in the Red Sea, and their regional effects, (10) exchange rate fluctuations, interest rate volatility and monetary policies and other changes in the regulatory climate in the countries in which the Company operates and/or sells products, (11) the effectiveness of the cost reduction programs implemented globally, including the successful implementation of procurement and sourcing initiatives and restructuring programs, (12) the successful commercialization of products and technology related to the energy solutions program, (13) political and economic uncertainties in the countries where the Company does business, as well as the effects of any withdrawals from such countries, (14) bankruptcy of or loss of major dealers, retail customers or suppliers, (15) introduction of new products by, more favorable product pricing offered by or shorter lead times available through competitors, (16) product liability or other litigation, warranty claims or returns of products, (17) changes mandated by federal, state and other regulation, including tax, health, safety or environmental legislation, (18) the ability to attract, retain, and replace workforce and administrative employees, (19) disruptions resulting from natural disasters, public health crises, political crises or other catastrophic events, and (20) the ability to protect the Company's information technology infrastructure against service interruptions, data corruption, cyber-based attacks or network breaches.

SOURCE Hyster-Yale, Inc.

Share this article

NEW YORK, Oct. 15, 2026 /PRNewswire/ -- Consolidated Edison, Inc. (Con Edison) (NYSE: ED) declared a quarterly dividend of 88.75 cents a share on its common stock, payable December 15, 2026 to stockholders of record as of November 18, 2026.

Consolidated Edison, Inc. is a holding company that provides a wide range of energy-related products and services to its customers through the following subsidiaries: Consolidated Edison Company of New York, Inc. (CECONY), a regulated utility providing electric service in New York City and New York's Westchester County, gas service in Manhattan, the Bronx, parts of Queens and parts of Westchester, and steam service in Manhattan; Orange and Rockland Utilities, Inc. (O&R), a regulated utility serving customers in a 1,300-square-mile area in southeastern New York State and northern New Jersey; and Con Edison Transmission, Inc., a regulated company primarily under the oversight of the Federal Energy Regulatory Commission, that develops and owns interests in electric transmission projects.

SOURCE Consolidated Edison, Inc.

Share this article